Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 609259, 16 pages
http://dx.doi.org/10.1155/2011/609259
Research Article

Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells

1Institute of Oral Biology and Biomaterial Science, Chung-Shan Medical University, Taichung 40201, Taiwan
2Department of Dentistry, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
3Division of Oral and Maxillofacial Surgery, Department of Stomatology, Taipei Veterans General Hospital, Taipei 11217, Taiwan
4Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
5Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan
6Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan
7Department of Pharmacy Practice, Tri-Service General Hospital and 114 National Defense Medical Center, Taipei, Taiwan

Received 28 May 2010; Accepted 15 August 2010

Academic Editor: Eric Deutsch

Copyright © 2011 Cheng-Chia Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. I. Haddad and D. M. Shin, “Recent advances in head and neck cancer,” The New England Journal of Medicine, vol. 359, no. 11, pp. 1143–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-J. Chen, J. T.-C. Chang, C.-T. Liao et al., “Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis,” Cancer Science, vol. 99, no. 8, pp. 1507–1514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. W.-L. Lo, S.-Y. Kao, L.-Y. Chi, Y.-K. Wong, and R. C.-S. Chang, “Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 7, pp. 751–758, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Their, “Epithelial-mesenchymal transitions in tumor progression,” Nature Reviews Cancer, vol. 2, no. 6, pp. 442–454, 2002. View at Google Scholar · View at Scopus
  5. J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Mani, W. Guo, M.-J. Liao et al., “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Batlle, E. Sancho, C. Franci et al., “The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells,” Nature Cell Biology, vol. 2, no. 2, pp. 84–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. B. P. Zhou, J. Deng, W. Xia et al., “Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition,” Nature Cell Biology, vol. 6, no. 10, pp. 931–940, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Yoshida, “Molecular genetics of human aldehyde dehydrogenase,” Pharmacogenetics, vol. 2, no. 4, pp. 139–147, 1992. View at Google Scholar · View at Scopus
  10. M. R. Clay, M. Tabor, J. H. Owen et al., “Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase,” Head Neck, vol. 32, no. 9, pp. 1195–1201, 2010. View at Google Scholar
  11. Z. G. Chen, “The cancer stem cell concept in progression of head and neck cancer,” Journal of Oncology, vol. 2009, Article ID 894064, 8 pages, 2009. View at Publisher · View at Google Scholar
  12. C. M. Sterz, C. Kulle, B. Dakic et al., “A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9,” Oral Oncology, vol. 46, no. 2, pp. 116–122, 2010. View at Publisher · View at Google Scholar
  13. Y.-C. Chen, Y.-W. Chen, H.-S. Hsu et al., “Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer,” Biochemical and Biophysical Research Communications, vol. 385, no. 3, pp. 307–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Pirrotta, “Polycombing the genome: PcG, trxG and chromatin silencing,” Cell, vol. 93, no. 3, pp. 333–336, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. V. Molofsky, R. Pardal, T. Iwashita, I.-K. Park, M. F. Clarke, and S. J. Morrison, “Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation,” Nature, vol. 425, no. 6961, pp. 962–967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. I.-K. Park, D. Qian, M. Kiel et al., “Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells,” Nature, vol. 423, no. 6937, pp. 302–305, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Sangiorgi and M. R. Capecchi, “Bmi1 is expressed in vivo in intestinal stem cells,” Nature Genetics, vol. 40, no. 7, pp. 915–920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Haupt, W. S. Alexander, G. Barri, S. P. Klinken, and J. M. Adams, “Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E μ-myc transgenic mice,” Cell, vol. 65, no. 5, pp. 753–763, 1991. View at Google Scholar · View at Scopus
  19. J. J. L. Jacobs, B. Scheijen, J.-W. Voncken, K. Kieboom, A. Berns, and M. Van Lohuizen, “Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF,” Genes and Development, vol. 13, no. 20, pp. 2678–2690, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. Z.-K. Qin, J.-A. Yang, Y.-L. Ye et al., “Expression of Bmi-1 is a prognostic marker in bladder cancer,” BMC Cancer, vol. 9, article 61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. S. Cooper and C. S. Foster, “Concepts of epigenetics in prostate cancer development,” British Journal of Cancer, vol. 100, no. 2, pp. 240–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Häyry, O. Tynninen, H. K. Haapasalo et al., “Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours,” Neuropathology and Applied Neurobiology, vol. 34, no. 5, pp. 555–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Tirabosco, G. De Maglio, M. Skrap, G. Falconieri, and S. Pizzolitto, “Expression of the polycomb-group protein BMI1 and correlation with p16 in astrocytomas. An immunohistochemical study on 80 cases,” Pathology Research and Practice, vol. 204, no. 9, pp. 625–631, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Arnes, K. Collett, and L. A. Akslen, “Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1,” Histopathology, vol. 52, no. 3, pp. 370–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Song, K. Tao, H. Li et al., “Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer,” Cancer Science, vol. 101, no. 7, pp. 1754–1760, 2010. View at Publisher · View at Google Scholar
  26. K. Vrzalikova, J. Skarda, J. Ehrmann et al., “Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 9, pp. 1037–1042, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Brunner, D. Thurnher, J. Pammer et al., “Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma,” Modern Pathology, vol. 21, no. 7, pp. 876–884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen, “Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes,” Cancer Letters, vol. 277, no. 2, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Jiang, B. Su, X. Meng et al., “Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells,” Cancer Science, vol. 101, no. 2, pp. 379–386, 2010. View at Publisher · View at Google Scholar
  30. D. W. Li, H. M. Tang, J. W. Fan et al., “Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 7, pp. 997–1006, 2010. View at Publisher · View at Google Scholar
  31. L. B. Song, J. Li, W. T. Liao et al., “The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells,” The Journal of Clinical Investigation, vol. 119, no. 12, pp. 3626–3636, 2009. View at Google Scholar
  32. C. C. Yu, G. Y. Chiou, Y. Y. Lee et al., “Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity,” Child's Nervous System, vol. 26, no. 7, pp. 897–904, 2010. View at Publisher · View at Google Scholar
  33. S.-H. Chiou, C.-L. Kao, Y.-W. Chen et al., “Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor,” PLoS ONE, vol. 3, no. 5, article e2090, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-H. Chiou, C.-C. Yu, C.-Y. Huang et al., “Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma,” Clinical Cancer Research, vol. 14, no. 13, pp. 4085–4095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. C. Chen, C. J. Chang, H. S. Hsu et al., “Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1,” Oral Oncology, vol. 46, no. 3, pp. 158–165, 2010. View at Publisher · View at Google Scholar
  36. M. Baumann, M. Krause, and R. Hill, “Exploring the role of cancer stem cells in radioresistance,” Nature Reviews Cancer, vol. 8, no. 7, pp. 545–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M.-H. Yang, M.-Z. Wu, S.-H. Chiou et al., “Direct regulation of TWIST by HIF-1α promotes metastasis,” Nature Cell Biology, vol. 10, no. 3, pp. 295–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. C. Chen, C. J. Chang, H. S. Hsu et al., “Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1,” Oral Oncology, vol. 46, no. 3, pp. 158–165, 2010. View at Google Scholar
  39. M. E. Prince, R. Sivanandan, A. Kaczorowski et al., “Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 973–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. G. V. Glinsky, O. Berezovska, and A. B. Glinskii, “Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1503–1521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Häyry, L. K. Mäkinen, T. Atula et al., “Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue,” British Journal of Cancer, vol. 102, no. 5, pp. 892–897, 2010. View at Publisher · View at Google Scholar
  42. P. Attner, J. Du, A. Näsman et al., “The role of human papillomavirus in the increased incidence of base of tongue cancer,” International Journal of Cancer, vol. 126, no. 12, pp. 2879–2884, 2010. View at Publisher · View at Google Scholar
  43. A. Salem, “Dismissing links between HPV and aggressive tongue cancer in young patients,” Annals of Oncology, vol. 21, no. 1, pp. 13–17, 2010. View at Google Scholar
  44. X.-H. Liang, J. Lewis, R. Foote, D. Smith, and D. Kademani, “Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience,” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 9, pp. 1875–1880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Dahlgren, H. Dahlstrand, D. Lindquist et al., “Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients,” International Journal of Cancer, vol. 112, no. 6, pp. 1015–1019, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Sano and J. N. Myers, “Metastasis of squamous cell carcinoma of the oral tongue,” Cancer and Metastasis Reviews, vol. 26, no. 3-4, pp. 645–662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. H. Kim, S. Y. Yoon, S.-H. Jeong et al., “Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer,” Breast, vol. 13, no. 5, pp. 383–388, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Silva, V. Garcia, J. M. Garcia et al., “Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients,” Breast Cancer Research, vol. 9, no. 4, p. R55, 2007. View at Google Scholar
  49. M. J. Hoenerhoff, I. Chu, D. Barkan et al., “BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases,” Oncogene, vol. 28, no. 34, pp. 3022–3032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Mihic-Probst, A. Kuster, S. Kilgus et al., “Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma,” International Journal of Cancer, vol. 121, no. 8, pp. 1764–1770, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. J.-H. Liu, L.-B. Song, X. Zhang et al., “Bmi-1 expression predicts prognosis for patients with gastric carcinoma,” Journal of Surgical Oncology, vol. 97, no. 3, pp. 267–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Yang, L. Chai, C. Gao et al., “SALL4 is a key regulator of survival and apoptosis in human leukemic cells,” Blood, vol. 112, no. 3, pp. 805–813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Yang, L. Chai, F. Liu et al., “Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 25, pp. 10494–10499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Shimono, M. Zabala, R. W. Cho et al., “Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells,” Cell, vol. 138, no. 3, pp. 592–603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Bhattacharya, M. Nicoloso, R. Arvizo et al., “MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer,” Cancer Research, vol. 69, no. 23, pp. 9090–9095, 2009. View at Google Scholar